Baqsimi · DIN 02492415 · 3 mg · Nas Pd Device
Limited Use, Reason for Use code 625 requiredMarketed · checked November 17, 2026
StatusLimited Use, Reason for Use code 625 required
Write on scriptReason for Use code 625 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 625
Reason for Use code 625
For the treatment of severe hypoglycemia (SH) reactions in patients with diabetes mellitus who are receiving insulin therapy and are at high risk for SH, when impaired consciousness precludes oral carbohydrate.
Coverage limit:
LU Authorization Period: 1 year
No interchangeable product listed in the Ontario extract
Baqsimi · DIN 02492415
Manufacturer: Amphastar Pharmaceuticals Inc.; listing date 2022-01-31
Health Canada: Marketed since 2024-09-23 · brand BAQSIMI · ATC H04AA01 GLUCAGON · form Powder · route Nasal · ingredients GLUCAGON 3 MG/CONTAINER · company Amphastar pharmaceuticals, inc. · schedule Ethical
Baqsimi: Formulary list price $160.52 per unit (the source does not state the unit; exact figure $160.5200). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02492415)
Source record
DIN 02492415: Baqsimi
Raw flags: sec12=Y, sec3=Y
Item: 920000739; group id 920; item number 2194; lccId 00351; manufacturer id AMP
Source form: Nas Pd Device; strength: 3mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $160.5200; ministry $160.5200
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02492415
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98243
Shortage status: not checked (no credentials)